Earnings calls

Thyrocare Tech. concall ledger

Every earnings call for THYROCARE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

THYROCARE · 6 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 12 May 2026Call held 12 May 2026

THYROCARE Q4 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹224 cr+20% YoYEBITDA₹262 cr+38% YoYEBITDA Margin34%PAT₹48.7 cr+128% YoYGross Margin74.7%

Consolidated Revenue (Q4 FY26) ₹224 cr (+20% YoY); EBITDA (FY26) ₹262 cr (+38% YoY); EBITDA Margin (Q4 FY26) 34%. Consolidated revenue grew 20% YoY in Q4 FY26 to INR224 crores and 21% YoY for FY26 to INR829 crores.

Read full transcript & analysis

Q3 FY26Published 28 Jan 2026Call held 28 Jan 2026

THYROCARE Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹196 cr+18% YoYEPS₹1.64+39% YoY

Consolidated Revenue ₹196 cr (+18% YoY); EPS ₹1.64 (+39% YoY). Consolidated revenue grew 18% YoY to INR 196 crores.

Read full transcript & analysis

Q1 FY26Published 14 Oct 2025Call held 14 Oct 2025

THYROCARE Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹217 cr+22% YoYNormalized EBITDA Margin34.8%Gross Margin71.6%EPS₹9.05+82% YoY

Revenue (Consolidated) ₹217 cr (+22% YoY); Normalized EBITDA Margin (Consolidated) 34.8%; Gross Margin (Standalone) 71.6%. Consolidated Revenue of ₹217 crores, up 22% YoY.

Read full transcript & analysis

Q4 FY25Published 23 Jul 2025Call held 23 Jul 2025

THYROCARE Q4 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue₹193 cr+23% YoYPAT₹38.06 cr+62% YoYStandalone Gross Margin71%

Consolidated Revenue ₹193 cr (+23% YoY); PAT ₹38 cr (+62% YoY); Standalone Gross Margin 71%. Consolidated revenue grew 23% year-on-year to ₹193 crores.

Read full transcript & analysis

Q3 FY25Published 23 Apr 2025Call held 23 Apr 2025

THYROCARE Q3 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue₹687 cr+20% YoYNormalized EBITDA₹210 crNormalized EBITDA Margin31%PAT₹101 cr+45% YoY

Consolidated Revenue ₹687 cr (+20% YoY); Normalized EBITDA ₹210 cr; Normalized EBITDA Margin (FY25) 31%. Consolidated revenue for FY25 reached INR687 crores, reflecting a robust 20% year-on-year growth.

Read full transcript & analysis

Q2 FY25Published 23 Jan 2025Call held 23 Jan 2025

THYROCARE Q2 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue₹166 cr+23% YoYConsolidated Gross Margin73%

Consolidated Revenue ₹166 cr (+23% YoY); Consolidated Gross Margin 73%. Consolidated revenue grew 23% YoY to INR166 crores.

Read full transcript & analysis